Bob, a director since 2011, joined Alta Partners, a leading life sciences venture capital firm, in October 2015. From July 2013 until July 2015, Bob was a Senior Advisor for the Bill and Melinda Gates Foundation and led the “Global Health Venture Initiative.” From 2008 until he joined the Gates Foundation, he was a General Partner and a member of the Biopharma Venture team at Frazier Healthcare. Prior to Frazier Healthcare, Bob was a Partner with Domain Associates, having joined the firm in 1996 as a Kauffman Fellow and becoming a Partner in 2000.
From 1997 to1998, Bob served as the Chief Operating Officer of Small Molecule Therapeutics, a Domain portfolio company subsequently purchased by Morphochem AG., and from 1992 to 1995, was in sales at Pharmacia Biotech. Prior to joining Pharmacia, Bob held a research position at Somatogen, a company developing a recombinant blood substitute that was subsequently bought by Baxter. While attending business school, Mr. More worked with MedVest, an early-stage venture group in Washington, D.C. Bob serves as an advisory board member for Greenspring Associates, Okapi Ventures, The Medical Industry Group of the NVCA and The Sulpizio Family Cardiovascular Center.
He is also a past founding board member of the Kauffman Fellows Program. Bob received his M.B.A. from the Darden School of Business Administration at the University of Virginia and a B.A. from Middlebury College.